Twist Bioscience's EBIT per Share for the
three
months ended in Dec. 2023 was $-0.75.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-3.58.
During the past 3 years, the average EBIT per Share Growth Rate was -6.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -6.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Twist Bioscience's EBIT per Share or its related term are showing as below:
TWST'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.5 Med: -6.2 Max: 1.2
Current: -6.6
During the past 8 years, the highest 3-Year average EBIT per Share Growth Rate of Twist Bioscience was 1.20% per year. The lowest was -19.50% per year. And the median was -6.20% per year.
TWST's 3-Year EBIT Growth Rate is ranked worse than 62.92% of 178
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.55
vs TWST: -6.60
The historical data trend for Twist Bioscience's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.58
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Twist Bioscience (NAS:TWST) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Twist Bioscience EBIT per Share Related Terms
Thank you for viewing the detailed overview of Twist Bioscience's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Twist Bioscience (Twist Bioscience) Business Description
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TWST has been successfully added to your 